Clinical Trials Resource Center

Therapeutic Areas: Dermatology | Rheumatology | Family Medicine

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Arizona Arthritis & Rheumatology Research, PLLC
Glendale Arizona 85304

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

California

Dermatology Specialists, Inc.
Oceanside California 92056

A national, multi-center, randomized, double-blind, 4 arm, 8 week study in subjects with psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs)

Dermatology Specialists, Inc.
Oceanside California 92056

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Dermatology Specialists, Inc.
Oceanside California 92056

You may be interested in learning about a clinical research study of an investigational study medication for symptoms associated with plaque psoriasis

Stanford University School of Medicine
Palo Alto California 94304

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Colorado

Colorado Medical Research Center, Inc.
Denver Colorado 80210

Are you suffering from moderate to severe plaque psoriasis?

Colorado Medical Research Center
Denver Colorado 80210

Are you suffering from moderate to severe plaque psoriasis?

Horizons Clinical Research Center, LLC
Denver Colorado 80220

Research Studies for the Treatment of PSORIASIS

Colorado Skin Care
Englewood Colorado 80129

A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of a new study drug in Subjects with Atopic Dermatitis and Plaque Psoriasis

Apex Dermatology
Littleton Colorado 80120

A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of a new study drug in Subjects with Atopic Dermatitis and Plaque Psoriasis

Connecticut

New England Research Associates, LLC
Trumbull Connecticut 06611

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Florida

Rheumatology Associates of Central Florida, PA
Orlando Florida 32806

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Millennium Research
Ormond Beach Florida 32174

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Arthritis Center, Inc.
Palm Harbor Florida 34684

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Integral Rheumatology & Immunology Specialists (IRIS)
Plantation Florida 33324

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

University of South Florida - Morsani Center for Advanced Healthcare
Tampa Florida 33612

A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis

Georgia

Columbus Regional Research Institute
Columbus Georgia 31904

Considering potential research options for managing psoriasis?

Indiana

Maryland

PAREXEL
Baltimore Maryland 21225

CHRONIC PLAQUE PSORIASIS

PAREXEL
Baltimore Maryland 21225

HIDRADENITIS SUPPURATIVA

PAREXEL
Baltimore Maryland 21225

PALMOPLANTAR PUSTULOSIS

The Center For Rheumatology And Bone Research
Wheaton Maryland 20902

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Massachusetts

ActivMed Practices & Research, Inc
Beverly Massachusetts 01915

Are you Suffering from Chronic Plaque Psoriasis?

Tufts Medical Center
Boston Massachusetts 02111

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Brigham & Women's Hospital
Boston Massachusetts 02115

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Clinical Pharmacology Study Group
Worcester Massachusetts 01605

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Minnesota

St. Paul Rheumatology, PA
Eagan Minnesota 55121

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Missouri

MediSearch Clinical Trials
St. Joseph Missouri 64506

A 30-day study evaluating a topical corticosteroid spray.

Clayton Medical Research
St. Louis Missouri 63117

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Nebraska

Physician Research Collaboration, LLC
Lincoln Nebraska 68516

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

New Jersey

NEW

Psoriasis Treatment Center of Central New Jersey
East Windsor New Jersey 08520

A phase 2A, randomized, double-blind, placebo-controoled, study to evaluate safety and efficacy of PF-06700841 in subjects with moderate to severe plaque psoriasis.

New York

Sadick Research Group
New York New York 10075

A Clinical Study to Assess the Safety and Efficacy of KD025 Administered Orally to Patients with Moderate to Severe Chronic Plaque Psoriasis

Sadick Research Group
New York New York 10075

A PHASE 3, MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE EFFICACY AND SAFETY OF APREMILAST IN SUBJECTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS OF THE SCALP

Mount Sinai St. Luke's
New York New York 10025

A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis

Sadick Research Group
New York New York 10075

A Study of a Topical foam for the treatment of Psoriasis Vulgaris

The Rockefeller University Hospital
New York New York 10065

Comparative analysis of small and large plaque psoriasis

Sadick Research Group
New York New York 10075

Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast.

North Carolina

Duke Clinical Research Unit
Durham North Carolina 27710

A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases

High Point Clinical Trials Center
High Point North Carolina 27265

Moderate to Severe Plaque Psoriasis Research Study

Ohio

Cincinnati Rheumatic Disease Study Group, Inc.
Cincinnati Ohio 45219

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Oklahoma

Pennsylvania

East Penn Rheumatology Associates, P.C.
Bethlehem Pennsylvania 18015

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor